Exactech Expands Medical Education Initiatives Through Its Own Channel on VuMedi
January 08 2014 - 11:06AM
Business Wire
Nearly 1000 Viewers Registered for Live
Shoulder Arthroplasty Webinar Jan 9th
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder, spine and
biologic materials, announced today Exactech CEO Bill Petty, MD, is
scheduled to moderate a live medical education webinar where nearly
1000 orthopaedic surgeons from around the world are registered to
share best practices and explore new concepts in shoulder
reconstruction. “New Concepts in Shoulder Arthroplasty” will air on
the website VuMedi on Thursday, January 9, from 8:00 – 9:30 PM
EST.
The faculty for this program includes four renowned shoulder
reconstruction specialists who will share their experiences using
Exactech’s Equinoxe® shoulder system to address challenges of
shoulder surgery.
- Joseph Zuckerman, MD, will present
“Subscap Sparing TSA: Indications, Rationale, Technique and
Pearls.”
- Howard Routman, DO, will present “New
Biomechanical Insights in Reverse Shoulders.”
- Greg Gilot, MD, will present “Augmented
Glenoid Solutions: Design Rationale & Technique Pearls.”
- Thomas Wright, MD, will present “Total
Shoulder Arthroplasty vs. Reverse: Clinical Outcomes.”
Participants in the webinar may submit questions to the
panelists and share their personal experiences through a chat room
environment. Surgeons interested in joining the webinar must
pre-register at http://www.vumedi.com/equinoxe.
The webinar marks Exactech’s official launch of its own channel
on VuMedi. The company plans to support the on-going education of
orthopaedic surgeons by providing cutting-edge educational videos
on hip, knee, shoulder, biologics and bone cement surgery and
techniques.
“Exactech is pleased to partner with VuMedi to provide this
educational opportunity for shoulder surgeons. As an orthopaedic
surgeon myself, I can appreciate the convenience of VuMedi’s forum
for education and exchange,” Petty said. “We at Exactech are eager
to use this channel to share valuable information on the use of our
implants and instrumentation to help improve outcomes for our
surgeons and their patients.”
The presentations in this webinar are based on papers recently
published in a special issue of the Bulletin of the Hospital for
Joint Diseases, which features 19 educational manuscripts on
shoulder arthroplasty. The supplement was supported through an
independent educational grant from Exactech.
For information about Exactech’s other medical educational
opportunities including surgical skills laboratories, visit
http://www.exac.com/medical-professionals/medical-education.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
About VuMedi
VuMedi is the YouTube for specialist physicians. It is the
largest community in the world of orthopaedic surgeons,
interventional cardiologists, radiologists, neurosurgeons, dental
and oral maxillofacial physicians that visit VuMedi daily to watch
expert videos, interact in discussions, participate in live
webinars, and receive continuing medical education credits.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
Exactech, Inc.Media Contact:Priscilla Bennett, APR,
352-377-1140Director of Marketing Communications and Public
Relationspriscilla.bennett@exac.comorInvestor contactsJody
Phillips, 352-377-1140Chief Financial OfficerorHawk AssociatesJulie
Marshall or Frank Hawkins, 305-451-1888E-mail:
exactech@hawkassociates.com
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2023 to Apr 2024